UBS’s iShares Biotechnology ETF IBB Stock Holding History

UBS’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$31.7M	Buy	347,400 +96,600	+39%	+$8.48M	0.02%	702
2014 Q2	$21.5M	Sell	250,800 -3,300	-1%	-$260K	0.02%	842
2014 Q1	$20M	Sell	254,100 -120,000	-32%	-$10M	0.02%	799
2013 Q4	$28.3M	Buy	374,100 +204,300	+120%	+$14.5M	0.03%	627
2013 Q3	$11.9M	Sell	169,800 -296,100	-64%	-$19.4M	0.01%	1005
2013 Q2	$27M	Buy	+465,900	New	+$26.9M	0.03%	519

Other funds holding IBB

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS's IBB Position: Q3 2014 in Review

UBS increased its iShares Biotechnology ETF (IBB) stake by 10% in Q3 2014, buying an estimated $29.3M and bringing the position to 3,673,590 shares worth $335M. The position accounts for 0.25% of the portfolio, ranked #78.

UBS first reported a position in IBB in Q2 2013 and has held it in 6 quarters since. 317 funds tracked by Wall St. Rank hold IBB as of Q3 2014.

UBS held 3,673,590 shares of iShares Biotechnology ETF worth $335M as of Q3 2014.
UBS bought 333,306 iShares Biotechnology ETF shares in Q3 2014, an estimated $29.3M.
iShares Biotechnology ETF made up 0.25% of UBS's portfolio in Q3 2014, its #78 holding.
UBS first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 6 quarters since.
317 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.